NOVARTIS AG (NVSEF)
Clinical trial NCT00201955 updates: 1. primary completion date: not set → 2006-07-01 2. enrollment: 740 → 762 participants 3. enrollment type: not set → ACTUAL 4. masking: DOUBLE → TRIPLE
Clinical trial NCT00201955 updates: 1. primary completion date: not set → 2006-07-01 2. enrollment: 740 → 762 participants 3. enrollment type: not set → ACTUAL 4. masking: DOUBLE → TRIPLE
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical